![]() Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | ||
Founding Date | Founding Date 1929 | Founding Date 2017 | Founding Date 1935 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more |
Employees | Employees 5,358 | Employees 8007% increase | Employees 27,764 |
Financial | |||
Revenue (est.) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) CHF220.6m (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) |
Cost of goods | Cost of goods €659.1m (FY, 2025) | Cost of goods CHF20.9m (FY, 2025) | Cost of goods ₹95.5b (FY, 2026) |
Gross profit | Gross profit €3.3b (FY, 2025) | Gross profit CHF214.3m (FY, 2025) | Gross profit ₹195b (FY, 2026) |
Net income | Net income €445.1m (FY, 2025) | Net income (CHF111.7m) (FY, 2025) | Net income ₹38.7b (FY, 2026) |

Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
View company
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company